September 20, 2013 Pharmaceutical and Therapeutic Committee
»
Items 1 & 2 - **DUE TO TECHNICAL DIFFICULTIES THESE ITEMS HAVE LOW AUDIO**
1. Call to Order.
2. Approval of Minutes from Aug. 16, 2013.
Items 1 & 2
**DUE TO TECHNICAL DIFFICULTIES THESE ITEMS HAVE LOW AUDIO**1. Call to Order.
2. Approval of Minutes from Aug. 16, 2013.
»
Item 3A - **DUE TO TECHNICAL DIFFICULTIES THE FIRST 10:51 OF THIS ITEM HAS LOW AUDIO LOW AUDIO**
Cytokine and Cell-Adhesion Molecules Antagonists
Item 3A
**DUE TO TECHNICAL DIFFICULTIES THE FIRST 10:51 OF THIS ITEM HAS LOW AUDIO LOW AUDIO**Cytokine and Cell-Adhesion Molecules Antagonists
»
Item 3B - Growth Hormone
Item 3B
Growth Hormone
»
Item 3C - Hypoglycemics, Incretin Enhancers/Mimetics
Item 3C
Hypoglycemics, Incretin Enhancers/Mimetics
»
Item 4 - Therapeutic and Clinical Drug Reviews and Updates: Chris Andrews, Pharm.D., Magellan Medicaid Administration.
Item 4
Therapeutic and Clinical Drug Reviews and Updates: Chris Andrews, Pharm.D., Magellan Medicaid Administration.
»
Executive Work Session - Pursuant to Texas Government Code, Chapter 531, and in accordance with Title 1,Texas Administrative Code, Part 15, Subchapter F, §354.1928, the Pharmaceutical and Therapeutics Committee may meet in Executive Session on one or more items listed under New Busin
Executive Work Session
Pursuant to Texas Government Code, Chapter 531, and in accordance with Title 1,Texas Administrative Code, Part 15, Subchapter F, §354.1928, the Pharmaceutical and Therapeutics Committee may meet in Executive Session on one or more items listed under New Busin
»
Items 6 & 7 - 6. Announcements of Drugs Recommended for the Medicaid PDL.
7. Adjourn.
Items 6 & 7
6. Announcements of Drugs Recommended for the Medicaid PDL.7. Adjourn.
